RankAlpha logo
Back to Rankings

LNTH

LantheusC
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
The Curium transaction provides a $102.50 cash anchor, potential CVR upside to $114.50, and a strategic combination spanning diagnostics and therapeutics. Lantheus also reported $92.2 million of operating cash flow and $593.3 million of cash at June 30, 2026.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-10-29 · BMO.
What can break
Curium transaction completion could be delayed or fail, leaving the stock exposed to standalone repricing.
Momentum
56
Value
60
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $102.50 · Bull $114.50 · Bear $88.00Analysis 2026-08-08; returns require an exact persisted reference.
Earnings
2026-10-29 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $106.06
Why
Momentum56 · Δ7d +11.7
Value60 · Δ7d +0.6
Sentiment49 · Δ7d +0.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-10-29 · BMO.
  • • Value remains the lead driver in the composite, 7D delta +0.6.

Contradictions & invalidation

  • • Curium transaction completion could be delayed or fail, leaving the stock exposed to standalone repricing.
  • • Lantheus suspended previously issued full-year 2026 guidance and will not hold a Q2 earnings call, reducing forward disclosure.
  • • Standalone momentum remains modest: Q2 revenue grew only 2.7%, PYLARIFY declined 4.1%, and adjusted EPS declined 1.3%.

Catalyst clock

2026-10-29 · BMO

Q2 results were operationally mixed and guidance was suspended

Lead driver: Value · See fundamentals
Momentum
56
8% active weight
Current posture
7d trendImproving
Δ7d
+11.7
Δ21d
+8.7
Value
60
47% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
+0.7
Sentiment
49
45% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-7.1
Why this grade

Composite grade C. Momentum 56.2 / Value 60.2 / Sentiment 49.4

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method

B+
Bull case
20%
Probability
Target price
$114.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Most likely
B
Base case
60%
Probability
Target price
$102.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$6.52B
Beta
-0.08
Shares Out
65.3M
P/E (TTM)
29.0
P/S (TTM)
3.00
P/FCF (TTM)
11.05
Rev YoY
+2.7%
EPS YoY
-0.8%
Gross Margin
+60.1%
Op Margin
+19.5%
Net Debt
$264.12M
Current Ratio
3.06
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data